BAIBYSTM Awarded Most Innovative Device in Life Science Startups at Biomed Israel 2026

TEL AVIV, Israel, May 15, 2026 — Biomed Israel 2026, the premier international life science conference in Israel, and 8400 The Health Network, announced today that Starget Pharma, caVos Biotech, Protai and BAIBYS™ are the winners of the startup showcase and competition for companies developing breakthrough technologies in the life sciences.

The panel of judges was comprised of representatives of VCs and multinational pharmaceutical and device companies from the US and Israel including: Anat Naschitz, 9vc; Reut Shema, PhD, aMoon; Neta-li Feuerstein Ganor, Eli Lilly; Adar Makovski Silverstein, PhD, Arkin Bio Ventures; Yael Gruenbaum-Cohen, PhD, Entree Bio Ventures; Irit Yaniv, MD, Almeda; Joseph Korff, ARC Ventures; Yair Benita, PhD, AION labs; Peter Kash, PhD, Camelot BioCapital and Amir Blatt, JJDC.

biomed-israel
From left to right: Haim Belinson, PhD, caVos Biotherapeutics; Sigal Kalmanson Cusnir, Starget Pharma; Eran Seger, Protai; Yaron Silberman, PhD, BAIBYS™ (Photo credit: Alexander Elman)

Related items